欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/1943/001
药品名称Albumeon
活性成分
    • albumin human 200.0 g/l
剂型Solution for infusion
上市许可持有人CSL Behring GmbH Emil-von-Behring-Straße 76 35041 Marburg
参考成员国 - 产品名称Germany (DE)
Albumeon
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Lithuania (LT)
      Human Albumin CSL Behring 200 g/l infuzinis tirpalas
    • Ireland (IE)
    • Iceland (IS)
    • France (FR)
    • Estonia (EE)
    • Belgium (BE)
    • Croatia (HR)
    • Slovenia (SI)
    • Slovakia (SK)
      Human Albumin CSL Behring 200 g/l
    • Romania (RO)
      Albumeon 200 g/l soluţie perfuzabilă
    • Czechia (CZ)
      Human Albumin CSL Behring 200 g/l
    • Cyprus (CY)
      ALBUMEON SOL FOR INF
    • Bulgaria (BG)
    • Hungary (HU)
      HUMAN ALBUMIN CSL BEHRING 200 g/l oldatos infúzió
    • Poland (PL)
      Human Albumin CSL Behring 200 g/l
    • Finland (FI)
    • Norway (NO)
      Albumin Behring
    • Greece (GR)
      ALBUMEON
    • Italy (IT)
    • Portugal (PT)
    • Spain (ES)
    • Austria (AT)
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Netherlands (NL)
    • Malta (MT)
      Albumeon® 20, 200 g/l solution for infusion
    • Latvia (LV)
      Human Albumin CSL Behring 200 g/l šķīdums infūzijām
许可日期2014/06/18
最近更新日期2024/08/10
药物ATC编码
    • B05AA01 albumin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Biological: Blood Product
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase